Exponent (NASDAQ:EXPO) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Exponent (NASDAQ:EXPOGet Free Report) issued its quarterly earnings data on Thursday. The business services provider reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.06, Zacks reports. Exponent had a return on equity of 27.73% and a net margin of 19.52%. During the same period in the previous year, the firm earned $0.41 earnings per share.

Exponent Stock Up 7.7 %

Shares of EXPO opened at $96.74 on Friday. The company has a market capitalization of $4.91 billion, a price-to-earnings ratio of 46.28 and a beta of 0.71. Exponent has a 52-week low of $74.30 and a 52-week high of $115.75. The stock has a 50 day moving average price of $92.13 and a 200 day moving average price of $100.83.

Exponent Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Friday, March 7th will be given a dividend of $0.30 per share. This is a boost from Exponent’s previous quarterly dividend of $0.28. This represents a $1.20 annualized dividend and a dividend yield of 1.24%. Exponent’s payout ratio is 54.11%.

Insider Activity at Exponent

In other news, Director Paul R. Johnston sold 7,000 shares of Exponent stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $98.32, for a total transaction of $688,240.00. Following the sale, the director now owns 59,406 shares in the company, valued at approximately $5,840,797.92. The trade was a 10.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 15,300 shares of company stock valued at $1,538,589 over the last ninety days. Insiders own 2.10% of the company’s stock.

About Exponent

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Earnings History for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.